|
2025 Journal Article Evaluating the impact of weight loss and accuracy of energy equations in Australians with amyotrophic lateral sclerosisSewell-Green, A., Capstick, R., Matthews-Rensch, K., Ngo, S., Henderson, R. and Steyn, F. (2025). Evaluating the impact of weight loss and accuracy of energy equations in Australians with amyotrophic lateral sclerosis. Clinical Nutrition ESPEN, 69, 1072. doi: 10.1016/j.clnesp.2025.07.788 |
|
2025 Journal Article To treat or not to treat: a scoping review of speech treatment for dysarthria in amyotrophic lateral sclerosis (ALS)Whelan, Brooke-Mai, Aldridge, Danielle, Ruhle, Jessica, Whitelock, Persephone, Taubert, Shana, Collins, Annette, Kearney, Elaine, Charania, Salma, Henderson, Robert D., Wallace, Sarah J., Mitchell, Claire, Stipancic, Kaila L., Kuruvilla-Dugdale, Mili and Vogel, Adam P. (2025). To treat or not to treat: a scoping review of speech treatment for dysarthria in amyotrophic lateral sclerosis (ALS). Healthcare, 13 (19) 2434, 1-22. doi: 10.3390/healthcare13192434 |
|
2025 Conference Publication Risk factors for dose-limiting, chronic and severe chemotherapy-induced peripheral neuropathyLi, Tiffany, Timmins, Hannah C., Horvath, Lisa G., Harrison, Michelle, Grimison, Peter, Friedlander, Michael, Marx, Gavin, Boyle, Frances, Wyld, David, Henderson, Robert, King, Tracy, Baron-Hay, Sally, Kiernan, Matthew C., Barnes, Elizabeth H., Goldstein, David and Park, Susanna B. (2025). Risk factors for dose-limiting, chronic and severe chemotherapy-induced peripheral neuropathy. Australian and New Zealand Association of Neurologists Clinical Neurophysiology Workshop, Gold Coast, QLD, Australia, 6-9 October 2024. Shannon, Ireland: Elsevier. doi: 10.1016/j.clinph.2025.2110921 |
|
2025 Journal Article Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruptionHoldom, Cory J., Williamson, James L., O’Reilly, Georgia, Henderson, Robert D., Neville, Sally, Ngo, Shyuan T., Dick, Taylor J. M. and Steyn, Frederik J. (2025). Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-11. doi: 10.1080/21678421.2025.2523945 |
|
2025 Journal Article An annotated multi-site and multi-contrast magnetic resonance imaging dataset for the study of the human tongue musculatureRibeiro, Fernanda L., Zhu, Xiangyun, Ye, Xincheng, Tu, Sicong, Ngo, Shyuan T., Henderson, Robert D., Steyn, Frederik J., Kiernan, Matthew C., Barth, Markus, Bollmann, Steffen and Shaw, Thomas B. (2025). An annotated multi-site and multi-contrast magnetic resonance imaging dataset for the study of the human tongue musculature. Scientific Data, 12 (1) 790, 790. doi: 10.1038/s41597-025-05092-8 |
|
2025 Journal Article An fMRI dataset for appetite neural correlates in people living with Motor Neuron DiseaseChang, Jeryn, Lv, JingLei, Guo, Christine C., Lucia, Diana, Bollmann, Saskia, Garner, Kelly, McCombe, Pamela A., Henderson, Robert D., Shaw, Thomas B., Steyn, Frederik J. and Ngo, Shyuan T. (2025). An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease. Scientific Data, 12 (1) 466, 466. doi: 10.1038/s41597-025-04828-w |
|
2025 Journal Article Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cuesChang, Jeryn, Shaw, Thomas B., McCombe, Pamela A., Henderson, Robert D., Lucia, Diana, Guo, Christine C., Lv, Jinglei, Garner, Kelly, Bollmann, Saskia, Ngo, Shyuan T. and Steyn, Frederik J. (2025). Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues. Brain Communications, 7 (2) fcaf111, 1-14. doi: 10.1093/braincomms/fcaf111 |
|
2025 Journal Article Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosisBuckett, Lauren E., Holdom, Cory J., Howe, Stephanie L., McCombe, Pamela A., Henderson, Robert D., Al-Chalabi, Ammar, Steyn, Frederik J. and Ngo, Shyuan T. (2025). Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (5-6), 485-494. doi: 10.1080/21678421.2025.2471429 |
|
2025 Journal Article Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating ScaleBadrising, Umesh A., Henderson, Robert, Reddel, Stephen, Corbett, Alastair, Liang, Christina, Reardon, Katrina, Ghaoui, Roula, Bulsara, Max, Brady, Stefen, Brusch, Anna, Chan, Doris, Coudert, Jerome D., Fairchild, Timothy, Jain, Gayatri, Kiernan, Matthew C., Leonard, Dag, Lloyd, Thomas, Schmidt, Jens, McDermot, Michael P., Sanders, Lauren, Lowe, Christine, van der Kooi, Anneke J., Weihl, Chris, Mohassel, Payam, Simpson, Marion, Carrol, Antonia, Cooper, Ian, Beer, Kelly, Hiscock, Krystyne ... Needham, Merrilee (2025). Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale. Clinical and Experimental Rheumatology, 43 (2), 316-325. doi: 10.55563/clinexprheumatol/zvffa0 |
|
2025 Journal Article Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysisNona, Robert J., Henderson, Robert D. and McCombe, Pamela A. (2025). Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (3-4), 1-19. doi: 10.1080/21678421.2024.2435976 |
|
2024 Journal Article Evaluation of NUN-004, a novel engineered ephrin antagonist, in healthy volunteers and patients with amyotrophic lateral sclerosis: a phase I/Ib, open-label, escalating dose and extended access studyGerometta, Michael, Henderson, Robert D., Friend, Richard, Cooper, Leanne T., Zhao, Jing, Boyd, Andrew W. and Bartlett, Perry F. (2024). Evaluation of NUN-004, a novel engineered ephrin antagonist, in healthy volunteers and patients with amyotrophic lateral sclerosis: a phase I/Ib, open-label, escalating dose and extended access study. Clinical Drug Investigation, 45 (1) e24636, 17-28. doi: 10.1007/s40261-024-01410-x |
|
2024 Journal Article Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunctionTu, Sicong, Li, Tiffany, Carroll, Antonia S., Mahoney, Colin J., Huynh, William, Park, Susanna B., Henderson, Robert, Vucic, Steve, Kiernan, Matthew C. and Lin, Cindy S-Y (2024). Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction. Scientific Reports, 14 (1) 18331, 18331. doi: 10.1038/s41598-024-69393-5 |
|
2024 Conference Publication Patient reported measures as the optimal assessment of chemotherapy-induced peripheral neuropathyLi, Tiffany, Timmins, Hannah C., Mahfouz, Fawaz M., Trinh, Terry, Mizrahi, David, Horvath, Lisa G., Harrison, Michelle, Grimison, Peter, Friedlander, Michael, Marx, Gavin, Boyle, Frances, Wyld, David, Henderson, Robert, King, Tracy, Baron-Hay, Sally, Kiernan, Matthew C., Rutherford, Claudia, Goldstein, David and Park, Susanna B. (2024). Patient reported measures as the optimal assessment of chemotherapy-induced peripheral neuropathy. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD, Australia, 13 - 15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14116 |
|
2024 Conference Publication Clinical risk factors associated with development of significant nerve damage during chemotherapyLi, Tiffany, Timmins, Hannah C., Horvath, Lisa G., Harrison, Michelle, Grimison, Peter, Friedlander, Michael, Marx, Gavin, Boyle, Frances, Wyld, David, Henderson, Robert, Baron-Hay, Sally, Kiernan, Matthew C., Barnes, Elizabeth H., Goldstein, David and Park, Susanna B. (2024). Clinical risk factors associated with development of significant nerve damage during chemotherapy. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD, Australia, 13 - 15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14117 |
|
2024 Journal Article Assessing the effect of Riluzole on motor unit discharge propertiesShandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053 |
|
2024 Journal Article Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymesTupil, Ajay R., Rivlin, Warwick, Mccombe, Pamela A., Henderson, Robert D., Rodgers, Jonathan and Vadlamudi, Lata (2024). Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes. Neurology Genetics, 10 (6) e200205, e200205. doi: 10.1212/nxg.0000000000200205 |
|
2024 Journal Article Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patientsJiang, Leanne, Tracey, Timothy J., Gill, Melinder K., Howe, Stephanie L., Power, Dominique T., Bharti, Vanda, McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2024). Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients. Stem Cell Research, 78 103447, 1-6. doi: 10.1016/j.scr.2024.103447 |
|
2024 Journal Article Stepping up for a practical biomarker of motor unit lossHenderson, Robert David and Shandiz, Ehsan (2024). Stepping up for a practical biomarker of motor unit loss. Muscle & Nerve, 70 (1), 1-3. doi: 10.1002/mus.28110 |
|
2024 Conference Publication Identifying optimized assessment of nerve damage during chemotherapyLi, Tiffany, Timmins, Hannah C, Mahfouz, Fawaz Mayez, Mizrahi, David, Horvath, Lisa, Harrison, Michelle L., Grimison, Peter S., Friedlander, Michael, Marx, Gavin M., Boyle, Frances M., Wyld, David, Henderson, Robert, King, Tracy, Baron-Hay, Sally E., Kiernan, Matthew C, Rutherford, Claudia, Goldstein, David and Park, Susanna B (2024). Identifying optimized assessment of nerve damage during chemotherapy. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.12016 |
|
2024 Journal Article Verbal and nonverbal fluency in amyotrophic lateral sclerosisBarker, Megan S., Ceslis, Amelia, Argall, Rosemary, McCombe, Pamela, Henderson, Robert D. and Robinson, Gail A. (2024). Verbal and nonverbal fluency in amyotrophic lateral sclerosis. Journal of Neuropsychology, 18 (2), 265-285. doi: 10.1111/jnp.12354 |
